Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Reducing Depression and Anxiety Among Teens [NA]
A completed clinical trial update from Aga Khan University investigating approaches to reduce depression and anxiety among teenagers; the do…
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Pilot Study: Investigating Mood Changes After Slow-wave Enhancement [NA]
This clinical trial update notes that the pilot study on mood changes after slow-wave enhancement has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: The Effects of Videogames on Depression Symptoms and Brain Dynamics [NA]
The study by Aalto University has completed evaluating the effects of videogames on depressive symptoms and brain dynamics in individuals wi…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Clinical Investigation of Wysa [NA]
Completed clinical trial evaluating Wysa for mental health issues including anxiety and depressive symptoms. Results were posted on 2025-02-…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)
This clinical trial update reports that the Janssen-sponsored study examining potential predictors of relapse in adults with major depressiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Mechanisms of Mindfulness-based Interventions
This Vanderbilt University Medical Center clinical trial explored the mechanisms of mindfulness-based interventions in depression, anxiety, …
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: A Transdiagnostic Course for Common Mental Health Problems in Primary Care [NA]
Completed trial evaluating a transdiagnostic course for depression and anxiety in primary care; results were posted on 2025-01-31.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Implementing and Evaluating an Internet-based Cognitive Behavior Therapy Intervention in School Settings [NA]
A Montana State University–led clinical trial evaluated an internet-based cognitive behavior therapy program implemented in school settings …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Pharmacogenomic Testing to Personalize Supportive Oncology [NA]
This completed clinical trial from Wake Forest University Health Sciences evaluated pharmacogenomic testing to personalize supportive oncolo…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase
This clinical trial update summarizes adverse drug reactions observed with cancer therapies in patients who have depression, using insights …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects [NA]
A completed clinical trial comparing brain metabolite patterns among euthymic individuals with bipolar disorder type II, major depressive di…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Investigating LIFUP in Anhedonic Depression [NA]
A UCLA-sponsored clinical trial evaluating low-intensity focused ultrasound (LIFUP) for anhedonic depression has completed.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluating the Effectiveness and Acceptability of a GPT-4o and RAG-Based Voice Chatbot for Depression Screening Using PHQ-9
A clinical study evaluating the effectiveness and acceptability of a GPT-4o and RAG-based voice chatbot for depression screening using the P…
-
FDA approval · 2025-01-29FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals USA's olanzapine and fluoxetine combination product.
-
FDA approval · 2025-01-29FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals' generic olanzapine and fluoxetine combination product.
-
FDA approval · 2025-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), authorizing the generic prod…
-
FDA approval · 2025-01-29FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)
FDA approved a supplemental application for Bupropion Hydrochloride sustained-release from Solco Healthcare US LLC, indicating approval of a…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCT [NA]
A pilot randomized controlled trial evaluating mindfulness-based cognitive therapy delivered via group videoconferencing for depressive symp…
-
FDA approval · 2025-01-29FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Bupropion hydrochloride by Alembic Pharmaceuticals Limited under the ANDA pathway, authorizing t…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions [NA]
Viome is conducting a clinical trial evaluating a nutritional program for mental health conditions. The study is active but not recruiting, …
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders [NA]
A Viome-sponsored clinical trial is evaluating precision nutritional programs to improve outcomes in mental health disorders, including majo…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: High Dose Accelerated iTBS for Depression [NA]
Completed clinical trial evaluating high-dose accelerated intermittent theta-burst stimulation (iTBS) for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment [Phase 2]
A Phase 2 clinical trial evaluating a single-dose ketamine treatment to improve depressive symptoms in individuals with mild cognitive impai…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: SALSA (Health, Food and Sociability): Community Networks for Healthy Eating, Autonomy, and Social Interaction [NA]
The SALSA trial evaluating community networks for healthy eating, autonomy, and social interaction has completed. Depression and anxiety are…
-
FDA approval · 2025-01-29FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic form of bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC.